Related Experiment Video
Updated: Jun 15, 2026

Generation of a Humanized Mouse Liver Using Human Hepatic Stem Cells
Published on: August 29, 2016
Developmental hyperbilirubinemia and CNS toxicity in mice humanized with the UDP glucuronosyltransferase 1 (UGT1)
Ryoichi Fujiwara1, Nghia Nguyen, Shujuan Chen
1Laboratory of Environmental Toxicology, Department of Chemistry and Biochemistry, University of California San Diego, La Jolla, CA 92093, USA.
Insights
High unconjugated bilirubin (UCB) in newborns can cause brain damage. This study modeled UCB accumulation in mice, revealing neonatal UCB toxicity independent of Gilbert
Area of Science:
- Biochemistry
- Genetics
- Neonatology
Background:
- High unconjugated bilirubin (UCB) in newborns is linked to reduced hepatic UDP glucuronosyltransferase (UGT) 1A1 activity, potentially causing central nervous system (CNS) toxicity.
- Mechanisms of UCB accumulation in brain tissue remain poorly understood.
- Gilbert's syndrome, a common clinical condition, involves a UGT1A1 promoter polymorphism contributing to hyperbilirubinemia in adults.
Purpose of the Study:
- To investigate the events leading to UCB accumulation in brain tissue by creating a mouse model.
- To compare UCB levels in neonatal mice expressing either the Gilbert's UGT1A1*28 allele or the normal UGT1A1*1 allele.
Main Methods:
- Humanized UGT1 mice expressing the human UGT1 locus (including UGT1A1) were generated in a Ugt1(-/-) background.
- Mice carrying either the UGT1A1*28 (Gilbert's) or UGT1A1*1 (normal) promoter alleles were monitored for hyperbilirubinemia.
- Total bilirubin (TB) levels were assessed during neonatal development and adulthood.
Main Results:
- Adult humanized UGT1 mice with the UGT1A1*28 allele showed elevated TB compared to those with the UGT1A1*1 allele, confirming the polymorphism's role in hyperbilirubinemia.
- Neonatal mice experienced TB accumulation to near-toxic levels, irrespective of the UGT1A1 promoter polymorphism.
- Neonatal TB clearance was not correlated with hepatic UGT1A1 expression; approximately 10% of mice exhibited seizures and mortality due to UCB brain deposition.
Conclusions:
- Neonatal hyperbilirubinemia and associated CNS toxicity in this model are independent of the Gilbert's syndrome UGT1A1 promoter polymorphism.
- UCB deposition and seizures in neonatal mice are linked to developmental stages and can be mitigated by enhancing UGT1A1 gene regulation.
Abstract:
High levels of unconjugated bilirubin (UCB) in newborn children is associated with a reduction in hepatic UDP glucuronosyltransferase (UGT) 1A1 activity that can lead to CNS toxicity, brain damage, and even death. Little is known regarding those events that lead to UCB accumulation in brain tissue, and therefore, we sought to duplicate this condition in mice. The human UGT1 locus, encoding all 9-UGT1A genes including UGT1A1, was expressed in Ugt1(-/-) mice. Because the most common clinical condition associated with jaundice in adults is Gilbert's syndrome, which is characterized by an allelic polymorphism in the UGT1A1 promoter, hyperbilirubinemia was monitored in humanized UGT1 mice that expressed either the Gilbert's UGT1A1*28 allele [Tg(UGT1(A1*28))Ugt1(-/-) mice] or the normal UGT1A1*1 allele [Tg(UGT1(A1*1))Ugt1(-/-) mice]. Adult Tg(UGT1(A1*28))Ugt1(-/-) mice expressed elevated levels of total bilirubin (TB) compared with Tg(UGT1(A1*1))Ugt1(-/-) mice, confirming that the promoter polymorphism associated with the UGT1A1*28 allele contributes to hyperbilirubinemia in mice. However, TB accumulated to near toxic levels during neonatal development, a finding that is independent of the Gilbert's UGT1A1*28 promoter polymorphism. Whereas serum TB levels eventually returned to adult levels, TB clearance in neonatal mice was not associated with hepatic UGT1A1 expression. In approximately 10% of the humanized UGT1 mice, peak TB levels culminated in seizures followed by death. UCB deposition in brain tissue and the ensuing seizures were associated with developmental milestones and can be prevented by enhancing regulation of the UGT1A1 gene in neonatal mice.
Related Concept Videos
Jaundice
Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase

